FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsGlobeNewsWire • 03/20/26
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities FraudBusiness Wire • 03/17/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGTPRNewsWire • 03/12/26
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026Business Wire • 02/12/26
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The StockSeeking Alpha • 01/27/26
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology PlatformZacks Investment Research • 12/23/25
Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/11/25
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/07/25
Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 ConferenceBusiness Wire • 10/20/25
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025Business Wire • 10/16/25
Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy)Seeking Alpha • 09/08/25